Clinical Trials in Phoenix

Showing 12081-12100 of 14,291 trials

Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers

NCT02119754

This is an open label study of subjects who have failed Protocol PGN-1300. Adult subjects (greater than 18 years old) who present with a mildly infected diabetic foot ulcer (IDSA criteria) having full thickness (i.e., through the dermis but not involving joint capsule, tendon, and bone) and have failed PGN-1300. Subjects must also provide informed consent and meet all other entry criteria to be enrolled and receive PluroGel PN.

Diabetic Foot UlcerInfection

PluroGen Therapeutics, Inc15 participantsStarted Oct 2013

Phoenix, Arizona, United States • Los Angeles, California, United States • Oakland, California, United States +12 more locations

COMPLETEDPhase 3< 1 mile

A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone

NCT01555164

This is a randomized, double-blind, placebo-controlled, parallel-group, multicenter study to determine the effect of ranolazine when added to metformin on glycemic control in adults with type 2 diabetes mellitus (T2DM) who are inadequately controlled despite current treatment with stable metformin therapy in addition to diet and exercise.

Type 2 Diabetes Mellitus

Gilead Sciences442 participantsStarted Jun 2012

Gulf Shores, Alabama, United States • Little Rock, Alaska, United States • Chandler, Arizona, United States +143 more locations

Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers

A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone

Find Trials by Condition in Phoenix

A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.

Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive Bladder

ADNI: Alzheimer's Disease Neuroimaging Initiative

A Study to Describe Pediatric Influenza Vaccine Coverage

A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid Arthritis

Evaluation of Corneal Epithelial Thickness Mapping

Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML

ACROSS-Cypher Total Occlusion Study of Coronary Arteries 4 Trial

Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia

Social and Communication Outcomes for Young Children With Autism

Autism Intervention Research Network for Behavioral Health (AIR-B II): Deployment Into Elementary Schools

Study of STA-9090, Administered Once-Weekly in Patients With Solid Tumors

A Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal Osteoporosis

Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose Influenza Virus Vaccines in Adults

Randomized Comparison Angioplasty Outcomes at Hospitals With and Without On-site Cardiac Surgery

Improving Clinician Communication Skills (ICCS)

Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL)

A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.